AIRVO 2, the new asymmetric nasal cannula

DEVICE2 trials

Sponsors

Temple University, IRCCS Azienda Ospedaliero-Universitaria di Bologna

Conditions

COPD Exacerbation AcuteChronic Obstructive Pulmonary Disease

Unknown Phase

Tolerance and Acute Effects of a New HFNT Nasal Cannula

CompletedNCT05182294

Temple UniversityCOPD Exacerbation Acute

Start: 2022-05-25End: 2023-01-31Updated: 2023-04-06

Effects on PaCO2 Levels of Two Different Nasal Cannula in COPD Patients

CompletedNCT05528289

IRCCS Azienda Ospedaliero-Universitaria di BolognaChronic Obstructive Pulmonary Disease

Start: 2022-08-04End: 2023-10-30Updated: 2024-06-21